Disease modification in ankylosing spondylitis

被引：0
|
作者：
Walter P. Maksymowych
机构：
[1] 562 Heritage Medical Research Building,Department of Medicine
[2] University of Alberta,undefined
来源：
Nature Reviews Rheumatology | 2010年 / 6卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Any form of treatment for patients with ankylosing spondylitis (AS) is defined as being disease-modifying on the basis of its ability to decrease inflammation, improve function and inhibit the progression of structural damage. This Review outlines clinical outcomes that are relevant to the concept of disease modification, looks at what is known about the disease-modifying properties of currently available agents and considers the challenges involved in developing future therapies for AS.
引用
收藏
页码：75 / 81
页数：6
相关论文
共 50 条
  • [21] Periodontal disease in patients with ankylosing spondylitis
    Pischon, N.
    Pischon, T.
    Guelmez, E.
    Kroeger, J.
    Purucker, P.
    Kleber, B-M
    Landau, H.
    Jost-Brinkmann, P-G
    Schlattmann, P.
    Zernicke, J.
    Burmester, G-R
    Bernimoulin, J-P
    Buttgereit, F.
    Detert, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2010, 69 (01) : 34 - 38
  • [22] Autoimmune thyroid disease in ankylosing spondylitis
    Emmungil, Hakan
    Erdogan, Mehmet
    Kalfa, Melike
    Karabulut, Gonca
    Kocanaogullari, Hayriye
    Inal, Vedat
    Aksu, Kenan
    Oksel, Fahrettin
    Kabasakal, Yasemin
    Keser, Gokhan
    CLINICAL RHEUMATOLOGY, 2014, 33 (07) : 955 - 961
  • [23] Disease and psychological status in ankylosing spondylitis
    Martindale, J.
    Smith, J.
    Sutton, C. J.
    Grennan, D.
    Goodacre, L.
    Goodacre, J. A.
    RHEUMATOLOGY, 2006, 45 (10) : 1288 - 1293
  • [24] WHIPPLE DISEASE AND ANKYLOSING-SPONDYLITIS
    BUSSIERE, JL
    EPIFANIE, JL
    LEBLANC, B
    SAUVEZIE, B
    MISSIOUX, D
    REVUE DU RHUMATISME, 1980, 47 (10): : 577 - 578
  • [25] Ankylosing spondylitis: an autoimmune or autoinflammatory disease?
    Daniele Mauro
    Ranjeny Thomas
    Giuliana Guggino
    Rik Lories
    Matthew A. Brown
    Francesco Ciccia
    Nature Reviews Rheumatology, 2021, 17 : 387 - 404
  • [26] Definition of disease duration in ankylosing spondylitis
    Ernst Feldtkeller
    Jon Erlendsson
    Rheumatology International, 2008, 28 : 693 - 696
  • [27] Subclinical cardiac disease in ankylosing spondylitis
    Ozen, Selin
    Ozen, Anil
    Unal, Ertekin U.
    Tufekcioglu, Omac
    Ataman, Sebnem
    Yalcin, Ayse P.
    ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED TECHNIQUES, 2018, 35 (10): : 1579 - 1586
  • [28] Autoimmune thyroid disease in ankylosing spondylitis
    Hakan Emmungil
    Mehmet Erdogan
    Melike Kalfa
    Gonca Karabulut
    Hayriye Kocanaogulları
    Vedat Inal
    Kenan Aksu
    Fahrettin Oksel
    Yasemin Kabasakal
    Gokhan Keser
    Clinical Rheumatology, 2014, 33 : 955 - 961
  • [29] INFLAMMATORY BOWEL DISEASE IN ANKYLOSING SPONDYLITIS
    JAYSON, MIV
    SALMON, PR
    HARRISON, WJ
    GUT, 1970, 11 (06) : 506 - +
  • [30] Definition of disease duration in ankylosing spondylitis
    Feldtkeller, Ernst
    Erlendsson, Jon
    RHEUMATOLOGY INTERNATIONAL, 2008, 28 (07) : 693 - 696
12345